Advertisement

Breast Cancer Research and Treatment

, Volume 40, Issue 1, pp 53–64 | Cite as

Timeliness of follow-up after abnormal screening mammography

Guest editor's introduction

Summary

Little information has been published concerning the timeliness of follow-up after abnormal mammography. This article presents data on follow-up after abnormal mammography, including differences in follow-up by age, race, mammographic interpretation, and type of tracking system. From unpublished data, the rate of timely follow-up 8 to 12 weeks after index abnormal mammography ranges from 69% to 99%. Women aged 65 and older, those of lower socioeconomic status, and those who are instructed to have repeat evaluations in four to six months have the highest proportion of untimely follow-up. With use of computer-based tracking systems, timely follow-up ranges from 89% to 99%. Computer-based tracking systems should be encouraged to promote timely follow-up of abnormal mammography. Further research is needed to better delineate those at risk for untimely follow-up after abnormal mammography, causes of untimely follow-up, the impact of untimely follow-up on breast cancer stage and mortality, and interventions that maximize timely follow-up.

Key words

follow-up screening mammography tracking 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brown ML, Houn F, Sickles EA, Kessler LG: Screening mammography in community practice: Positive predictive value of abnormal findings and the yield of follow-up diagnostic procedures. Am J Roentgenol 165:1373–1377, 1995Google Scholar
  2. 2.
    Tabar L, Fagerberg G, Duffy SW, Day NE, Gas A, Grontoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30:187–210, 1992PubMedGoogle Scholar
  3. 3.
    Andersson I, Aspergren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfusson B: Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 297:943–948, 1988PubMedGoogle Scholar
  4. 4.
    Elwood JM, Cox B, Richardson AK: The effectiveness of breast cancer screening by mammography in younger women. On-line J Cur Clin Trials 2:Doc NR 32, 1993Google Scholar
  5. 5.
    Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S: Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85:1644–1656, 1993PubMedGoogle Scholar
  6. 6.
    Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL: Efficacy of screening mammography: A meta-analysis. JAMA 273:149–154, 1995PubMedGoogle Scholar
  7. 7.
    Moskowitz M: Breast cancer: age-specific growth rates and screening strategies. Radiology 161:37–41, 1986PubMedGoogle Scholar
  8. 8.
    Spratt JS, Greenberg RA, Heuser LS: Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening. Cancer Res 46:970–974, 1986PubMedGoogle Scholar
  9. 9.
    Facione NC: Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay: Soc Sci Med 36:1521–1534, 1993PubMedGoogle Scholar
  10. 10.
    Caplan LS, Helzlsouer KJ: Delay in breast cancer: A review of the literature. Public Health Rev 20:187–214, 1992/93Google Scholar
  11. 11.
    Vernon SW, Tilley B, Neale AV, Steinfeldt L: Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer 55:1563–1571, 1985PubMedGoogle Scholar
  12. 12.
    Charlson ME: Delay in the treatment of carcinoma of the breast. Surg Gynecol Obstet 160:393–399, 1985PubMedGoogle Scholar
  13. 13.
    Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M: Patient's and doctor's delay in primary breast cancer. Acta Oncologica 33:345–351, 1994PubMedGoogle Scholar
  14. 14.
    Machiavelli M, Leone B, Romero A, Perez J, Vallejo C, Bianco A, Rodriguez R: Relation between delay and survival in 596 patients with breast cancer. Oncology 46:78–82, 1989PubMedGoogle Scholar
  15. 15.
    Neave LM, Mason BH, Kay RG: Does delay in diagnosis of breast cancer affect survival? Breast Cancer Res Treat 15:103–108, 1990PubMedGoogle Scholar
  16. 16.
    Kerlikowske K, Grady D, Barclay J, Sickles E, Eaton A, Ernster V: Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270:2444–2450, 1993PubMedGoogle Scholar
  17. 17.
    Houn F, Brown ML: Current practice of screening mammography in the United States: data from the National Survey of Mammography Facilities. Radiology 190:209–215, 1994PubMedGoogle Scholar
  18. 18.
    CDC: Results from the National Breast and Cervical Cancer Early Detection Program, October 31, 1991–September 30, 1993. MMWR 43:530–534, 1994Google Scholar
  19. 19.
    CDC: Public health focus: mammography. MMWR 41:454–459, 1992Google Scholar
  20. 20.
    Webber P, Fox P, Pond M, Zhang X: An examination of differential follow-up rates in breast cancer screening. Journal of Community Health 21:123–132, 1996PubMedGoogle Scholar
  21. 21.
    Sickles EA: Quality assurance. How to audit your own practice. Radiol Clin North Am 30:265–275, 1992PubMedGoogle Scholar
  22. 22.
    Ciatto S, Cecchini S, Rosselli Del Turco M, Grazzini G, Iossa A, Bartoli D: Referral policy and positive predictive value of call for surgical biopsy in the Florence Breast Cancer Screening Program. J Clin Epidemiol 43:419–423, 1990PubMedGoogle Scholar
  23. 23.
    Bird RE: Low-cost screening mammography: report on finances and review of 21,716 consecutive cases. Radiology 171:87–90, 1989PubMedGoogle Scholar
  24. 24.
    Pillsbury SG, Link JS, Roux S: Improved mammographic accuracy. Obstet Gynecol 164:1643–1646, 1991Google Scholar
  25. 25.
    Sickles EA, Ominsky SH, Sollitto RA, Galvin HB, Monticciolo DL: Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology 175:323–327, 1990PubMedGoogle Scholar
  26. 26.
    D'Orsi CJ, Kopans DB: Mammographic feature analysis. Seminars in Roentgenology 28:204–230, 1993PubMedGoogle Scholar
  27. 27.
    McCarthy BD, Boohaker EA, Ulcickas M, Wilcock CH, Ward RE: Inadequate follow-up of abnormal mammograms. J Gen Int Med 9(April Supplement 2):33, 1994Google Scholar
  28. 28.
    Clay MG, Hislop TG, Kan L, Olivotto IA, Burhenne LJW: Screening mammography in British Columbia: 1988–1993. Am J Surg 167:490–492, 1994PubMedGoogle Scholar
  29. 29.
    Burhenne LJW: 1990 Annual Report of Screening Mammography Program in British Columbia, p 32Google Scholar
  30. 30.
    Helvie MA, Pennes DR, Rebner M, Adler DD: Mammographic follow-up of low-suspicion lesions: compliance rate and diagnostic yield. Radiology 178:155–158, 1991PubMedGoogle Scholar
  31. 31.
    Fox SA, Roetzheim RG: Screening mammography and older women. Cancer 74:2028–2033, 1994PubMedGoogle Scholar
  32. 32.
    Richardson JL, Marks G, Solis JM, Collins L, Birba L, Hisserich JC: Frequency and adequacy of breast cancer screening among elderly Hispanic women. Prev Med 16:761–774, 1987PubMedGoogle Scholar
  33. 33.
    Breen N, Kessler L: Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Survey. Am J Public Health 84:62–67, 1994PubMedGoogle Scholar
  34. 34.
    Lacey LL, Whitfield J, DeWhite W, Ansell D, Whitman S, Chen E, Phillips C: Referral adherence in an inner city breast and cervical cancer screening program. Cancer 72:950–955, 1993PubMedGoogle Scholar
  35. 35.
    Manfredi C, Lacey L, Warnecke R: Results of an intervention to improve compliance with referrals for evaluation of suspected malignancies at neighborhood public health centers. Am J Public Health 80:85–87, 1990PubMedGoogle Scholar
  36. 36.
    Sickles EA: Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 179:463–468, 1991PubMedGoogle Scholar
  37. 37.
    Sickles EA: Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient. Radiology 192:439–442, 1994PubMedGoogle Scholar
  38. 38.
    Mandelblatt J, Traxler M, Lakin P, Kanetsky P, Thomas L, Chauhan P, Matseoane S, Ramsey E, and the Harlem Study Team: Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Am J Prev Med 9:133–138, 1993PubMedGoogle Scholar
  39. 39.
    Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 165:658–662, 1991PubMedGoogle Scholar
  40. 40.
    Spratt JA, von Fournier D, Spratt JS, Weber EE: Mammographic assessment of human breast cancer growth and duration. Cancer 71:2020–2026, 1993PubMedGoogle Scholar
  41. 41.
    Kern KA: Causes of breast cancer malpractice litigation. Arch Surg 127:542–547, 1992PubMedGoogle Scholar
  42. 42.
    Kern KA: Medicolegal analysis of the delayed diagnosis of cancer in 338 cases in the United States. Arch Surg 129:397–404, 1994PubMedGoogle Scholar
  43. 43.
    Mitnick JS, Vazquez MF, Plesser KP, Rosess DF: Breast cancer malpractice litigation in New York state. Radiology 189:673–676, 1993PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  1. 1.Department of Epidemiology and BiostatisticsUniversity of CaliforniaSan FranciscoUSA
  2. 2.General Internal Medicine SectionDepartment of Veterans Affairs Medical CenterSan FranciscoUSA

Personalised recommendations